DERM News and Press, Journey Medical Corporation From 03/21/24

2024-03-21 20:22:02 ET Journey Medical Corporation (DERM) Q4 2023 Earnings Conference Call March 21, 2024 04:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Founder, President and CEO Joseph Benesch - Interim...

2024-03-21 16:04:13 ET More on Journey Medical Journey Medical announces U.S. FDA acceptance of NDA for its rosacea treatment Journey Medical submits NDA for DFD-29 for rosacea Seeking Alpha’s Quant Rating on Journey Medical Historical earnings data fo...

Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 Achieved $15.6 million in operating cost savings in 2023, ahead of initial guidance of $...

X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...

2024-03-20 17:35:53 ET More on Journey Medical Journey Medical announces U.S. FDA acceptance of NDA for its rosacea treatment Journey Medical submits NDA for DFD-29 for rosacea Seeking Alpha’s Quant Rating on Journey Medical Historical earnings data fo...

2024-03-20 17:35:09 ET Major earnings expected after the bell on Thursday include: NIKE ( NKE ) FedEx Corporation ( FDX ) Lululemon Athletica ( LULU ) Asensus Surgical ( ASXC ) AAR Corp. ( AIR ) Read the full article on Seeking Alpha F...

2024-03-18 09:17:32 ET More on Journey Medical Journey Medical submits NDA for DFD-29 for rosacea Journey Medical secures credit facility for up to $20M Seeking Alpha’s Quant Rating on Journey Medical Historical earnings data for Journey Medical ...

SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (&#...

SCOTTSDALE, Ariz., March 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the selling and marketing of FDA-approved prescription pharmaceutical produc...

SCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment ...